Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;36(4):e70074.
doi: 10.1111/pai.70074.

Invasive fungal disease in a large cohort of hospitalized children with inborn errors of immunity in China

Affiliations

Invasive fungal disease in a large cohort of hospitalized children with inborn errors of immunity in China

Haiqiao Zhang et al. Pediatr Allergy Immunol. 2025 Apr.

Abstract

Background: Invasive fungal disease (IFD) is a common complication observed in inborn errors of immunodeficiency (IEI) patients, and little is known about the overall prevalence of IFD in IEI patients. We aimed to summarize the fungal spectrum and outcomes of IFDs in a Chinese cohort of hospitalized patients with IEI.

Methods: In this retrospective study, 607 IEI patients hospitalized from January 2018 to June 2022 were included. Demographic, clinical, and fungal infection data and IEI patient characteristics were collected and analyzed according to the IEI classification.

Results: One hundred and two IEI patients were diagnosed with proven or probable IFD. The overall prevalence of IFD was 17% (102/607). There were 29 different genotypes, among which CYBB (25%), CD40LG (9%), and RAG1 (7%) mutations were the most common. Most IFD infections (87/102) were caused by one fungus. Invasive Aspergillus, Pneumocystis jirovecii pneumonia, and Penicillium infections were more commonly observed in patients with congenital defects in phagocytes, immunodeficiencies affecting cellular and humoral immunity, and defects in innate immunity, respectively. Most IFDs observed in IEI patients were single-site infections, most of which were lung infections (74%). Seventeen patients were diagnosed with disseminated IFDs, nine of which were caused by Penicillium. All patients received antifungal treatments. Eight patients (8%) died within 3 months of IFD diagnosis.

Conclusions: IFD occurrence suggests the presence of immunity impairment. The IFD fungal profile may indicate different types of IEI. Early recognition of immunodeficiency and optimal timing of antifungal therapy can reduce fatality in IEI patients.

Keywords: SCID; fungal spectrum; inborn errors of immunity; invasive fungal disease; metagenomic next‐generation sequencing.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Jenks JD, Cornely OA, Chen SC, Thompson GR, Hoenigl M. Breakthrough invasive fungal infections: who is at risk? Mycoses. 2020;63:1021‐1032.
    1. Cifaldi C, Ursu GM, D'Alba I, et al. Main human inborn errors of immunity leading to fungal infections. Clin Microbiol Infect. 2022;28:1435‐1440.
    1. Lionakis MS. Primary immunodeficiencies and invasive fungal infection: when to suspect and how to diagnose and manage. Curr Opin Infect Dis. 2019;32:531‐537.
    1. Lionakis MS, Iliev ID, Hohl TM. Immunity against fungi. JCI Insight. 2017;2(11):e93156. doi:10.1172/jci.insight.93156
    1. Lionakis MS, Levitz SM. Host control of fungal infections: lessons from basic studies and human cohorts. Annu Rev Immunol. 2018;36:157‐191.

LinkOut - more resources